AzTrials
AzTrials

Tobacco Smoke PollutionNCT00757224

Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants

A study testing Guidance in people with Tobacco Smoke Pollution, run by Assaf-Harofeh Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Parental smoking is associated with increased frequency of respiratory diseases including hospitalizations in infants. Study hypothesis: Parental education regarding the association between parental smoking and respiratory diseases in the infant, and guidance on ways to decrease smoke exposure by the infant, provided… Read more about this study

Who is it for?
Ages 1 day to 3 daysHealthy volunteers can take part
Conditions the study is for
Tobacco Smoke Pollution
What is being tested?
Guidance
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteIsrael
Study dates
Oct 2008to Oct 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 3 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Infants born at Asaf Harofeh Medical Center
  • Infants born at >35W gestational age

Who cannot join

  • Infants requiring any supportive treatment (supplemental O2, fluids, glucose, antibiotics)

Trial locations and contacts

1 site in 1 country.

Arnon Elizur, MD contact

972-8-9779817

elizura@gmail.com

Israel1 site
  • Asaf Harofeh Medical Center

    Tsrifin, 70300

    Arnon Elizur, MD, 972-8-9779817, elizura@gmail.com

Other trials in Israel

About this study

Parental smoking is associated with increased frequency of respiratory diseases including hospitalizations in infants.

Study hypothesis: Parental education regarding the association between parental smoking and respiratory diseases in the infant, and guidance on ways to decrease smoke exposure by the infant, provided shortly after the infant is born, will decrease infants' morbidity.

Read the detailed description

Mothers who are in Maternity ward following birth will fill a questionnaire regarding smoking habits. Parents will be divided into non-smokers and smokers. Half of the smoking mothers will receive guidance regarding the association between parents smoking and respiratory diseases in the infant. They will also get ideas on how to reduce smoke exposure by their infant. 3 months and 1 year later all parents will be contacted by phone and asked about their children's health.

Being tested
Guidance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GuidanceBehavioural

    Smoking parents will receive education on the association between parental smoking and respiratory morbidity in the infant. They will also be offered ways to reduce smoke exposure of their infants.

Study groups in NCT00757224
Study groupRoleWhat they receive
non-smokingNo interventionNot described
smoking parents ANo interventionNot described
smoking parents BExperimentalParents will be educated on the hazards of passive smoke exposure and ways to reduce it
Receives: Behavioral: Guidance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of episodes of cough/wheeze/asthma/bronchitis during the first 3 months and 1 year.

    Measured: 3 months and 1 year

Secondary outcomes (1)
  1. The number of ED visits and hospitalizations for respiratory diseases in the first 3 months and 1 year

    Measured: 3 months and 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2008 (estimated)
  2. Study startOct 2008
  3. Primary completionNov 2008 (estimated)
  4. Study completionOct 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00757224
Sponsor's protocol ID
147/08
Status last verified
Sep 2008
First submitted
21 Sep 2008
Last updated
23 Sep 2008
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Guidance in people with Tobacco Smoke Pollution, run by Assaf-Harofeh Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Sep 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Arnon Elizur, MD (972-8-9779817, elizura@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of episodes of cough/wheeze/asthma/bronchitis during the first 3 months and 1 year. (time frame: 3 months and 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in